94.8 F
Fort Worth
Tuesday, August 11, 2020

FDA approves over-the-counter sale for Alcon allergy eye drops

Other News

More screen time causing concern

You might not know that there is a Dry Eye Awareness Month. But Alcon does, and it has...

Council Report: Alcon, Bell Metal project updates

Rick Mauch FWBP Contributor ALCON ENTERPRIZE ZONE PROJECT STATUS UPDATE    The Fort Worth City...

Alcon (SIX/NYSE: ALC) announced July 14 that Pataday Once Daily Relief Extra Strength (olopatadine hydrochloride ophthalmic solution 0.7%), formerly prescribed as Pazeo, has been approved by the Food and Drug Administration for sale over-the-counter in the United States.

Pataday Once Daily Relief Extra Strength is the first and only once daily eye allergy itch drop offering a full 24 hours of relief without a prescription, the company said in a news release.

Alcon said allergies are the sixth-leading cause of chronic illness in the U.S., generating approximately $2.7 billion in over-the-counter retail sales.

“Alcon is thrilled to bring another needed innovation to the millions of people in the U.S. who suffer from itchy allergy eyes,” said Sergio Duplan, Region President of North America at Alcon. “With Pataday Once Daily Relief Extra Strength, eye allergy sufferers will get over-the-counter eye allergy itch relief that lasts a full 24 hours. We’re excited to bring more customer options to the Pataday product portfolio, which is already the number one eye allergy brand in the U.S. OTC market.”

This formulation joins Pataday Once Daily Relief (olopatadine hydrochloride ophthalmic solution 0.2%) and Pataday Twice Daily Relief (olopatadine hydrochloride ophthalmic solution 0.1%), which were approved for sale over-the-counter in February 2020.

The Pataday brand contains olopatadine, the #1 doctor prescribed active ingredient for eye allergy relief. Since 2008, over 40 million prescriptions have been written for olopatadine.

Alcon secured the rights to switch prescription products using the active ingredient olopatadine to over-the-counter as part of its separation from Novartis in April 2019.

Both Pataday Twice Daily Relief and Pataday Once Daily Relief are available now in all major food, drug and mass retailers nationally, the company said in the news release.

Pataday Once Daily Relief Extra Strength will be available online beginning in September, ahead of national retail availability in February 2021.

 In the meantime, patients should speak with their doctor or pharmacy regarding existing prescription refills.

More information: www.Pataday24hour.com

– FWBP Staff

- Advertisement -
- Advertisement -

Latest News

Fort Worth Council approves contract for COVID housing

The Fort Worth City Council approved a $9.3 million proposal to turn unused hotel space into permanent supportive housing for people impacted...

New Zealand scrambles to find source of new virus infections

By NICK PERRY Associated PressWELLINGTON, New Zealand (AP) — Health authorities in New Zealand were scrambling Wednesday to trace the source of...

Tarrant County reports 5 COVID deaths

Tarrant County Public Health on Tuesday, Aug. 11 reported five COVID-19 deaths. The deceased include two men from Fort Worth, one in...

Health officials are quitting or getting fired amid outbreak

By MICHELLE R. SMITH and LAUREN WEBER Associated Press and KHNPROVIDENCE, R.I. (AP) — Vilified, threatened with violence and in some cases...

How to use ventilation and air filtration to prevent the spread of coronavirus indoors

Shelly Miller, University of Colorado Boulder The vast majority...